Short answer
ORTHOPEDIATRICS CORP (KIDS) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 earnings release for the quarter ended September 30, 2026.
ORTHOPEDIATRICS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 earnings release for the quarter ended September 30, 2026
- Unaudited condensed consolidated financial statements included in Exhibit 99.1
- Investor focus: quarterly results, financial position and guidance disclosures in the accompanying release
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $72.7M, up 19%, with Trauma and Deformity $52.6M and Scoliosis $19.2M driving growth
- Adjusted EBITDA $6.9M, up from $6.2M, while gross margin held at 74%
- Free cash flow improved to $1.6M from $3.4M usage, but nine-month free cash flow remained negative $6.6M
- 2026 revenue guidance raised to $270.0M-$273.0M, with adjusted EBITDA approximately $25.0M and breakeven free cash flow reiterated
- Cash, investments and restricted cash fell to $44.9M from $62.9M at December 31, 2025, warranting liquidity monitoring despite operating improvement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ORTHOPEDIATRICS CORP 8-K filings
Get the next KIDS 8-K as it lands
Follow KIDS for push alerts, or ask the research agent what this filing means.